CDC's HIV, Viral Hepatitis, STD, and Tuberculosis Prevention Budget

At a glance

  • CDC prioritizes cost-effective, scalable interventions, policies, and research to reduce the incidence of HIV, viral hepatitis, STIs, and Tuberculosis.
  • CDC investments fund state, local and territorial health departments, community-based organizations, national organizations, academic institutions, and education agencies.
  • These prevention and treatment programs are essential to the nation’s public health infrastructure.
A clinician provides care to a patient.

Funding overview

CDC funding and training support field staff, including Disease Intervention Specialists (DIS). DIS are frontline public health staff who help identify individuals who may not know they were exposed to STIs, HIV, and tuberculosis. These specially trained staff then connect patients to testing and treatment. DIS are also a critical piece of the public health infrastructure when emergencies and public health threats emerge, protecting Americans from a wide variety of outbreaks and epidemics, including HIV, tuberculosis, Ebola, influenza, Zika, and COVID-19.

CDC also provides financial assistance and assigns federal employees with on-the-ground experience to state, tribal, local and territorial health departments to reduce HIV, viral hepatitis, STI, and tuberculosis infections, link those who test positive to care and treatment, and prevent death. Upon request from state, tribal, local, and territorial health departments, CDC can provide direct assistance, which may include deploying CDC public health advisors or epidemiologists to assist with disease investigations.

How is CDC funding used for HIV, viral hepatitis, STIs, tuberculosis prevention?

In FY 2023, the U.S. Congress enacted a spending bill that appropriated $1,391,056,000 to CDC to prevent and control HIV, viral hepatitis, STIs, tuberculosis, infectious diseases and the opioid epidemic, and to promote adolescent and school health. The FY 2023 operating budget1 amount was $1,281,310,018:

  • Approximately 76% of the operating budget was awarded through extramural mechanisms. The majority of this funding is awarded to state, tribal, local, and territorial health departments, community-based organizations, national organizations, academic institutions, and education agencies as grants and cooperative agreements.
  • Approximately 24% of the operating budget was spent on internal CDC resources that enable the nation's response to infectious disease, including world-class laboratories, outbreak response, cutting-edge research, and technical assistance to health departments and community-based organizations.

These expenditures achieved measurable reduction in risk factors, illness, and death in communities at all levels of social status.


CDC uses a comprehensive approach to stop the spread of infectious diseases among people who use drugs. The nation’s public health crisis involving drug use of opioids and other drugs, including methamphetamines and cocaine, is fueling increases in infectious diseases, such as viral hepatitis and HIV.

HIV, viral hepatitis, STI, and tuberculosis laboratory services at CDC work around the clock to protect the health of all Americans. These laboratories use vital discoveries and cutting-edge technology, some of which are only available at CDC laboratories.

Funding over time

  • FY 2020 - FY 2024 funding reflects enacted amounts.
  • FY 2020 - FY 2024 enacted amounts include funding for Infectious Diseases and the Opioid Epidemic.
  • Enacted: The amount in the spending bill passed by both chambers of Congress and made into law.
  1. Operating budget: Amount of funding obligated by an organization during the fiscal year to meet both routine business costs and program needs.